80 results on '"Álvarez‐Navascués, Carmen"'
Search Results
2. Predictive models for hepatocellular carcinoma development after sustained virological response in advanced hepatitis C
3. Liver Transplantation for Porto-Sinusoidal Vascular Liver Disorder: Long-term Outcome
4. Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebo-controlled trial
5. Predictive models of treatment benefit in patients with autoimmune hepatitis and decompensated cirrhosis at diagnosis
6. Risk of decompensated cirrhosis in patients with primary biliary cholangitis under first, second and third-line therapies
7. Variation in the presentation pattern of primary biliary cholangitis (PBC) in Spain according to the diagnostic period: data from the Spanish registry of cholestatic and autoimmune liver diseases (COLHAI)
8. Efficacy and safety of vaccination againts SARS-CoV-2 in patients with vascular liver disease
9. The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolization
10. Sarcoidosis sistémica con afectación gastrointestinal y hepática
11. Isolated IgG elevation is not associated with worse outcome in patients with autoimmune hepatitis
12. Rituximab is a safe and effective treatment for patients with autoimmune hepatitis: results from the Spanish registry for cholestatic and autoimmune hepatitis
13. Disulfiram hepatotoxicity: Report of three cases
14. Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome
15. Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study
16. Evaluation of cardiovascular events in patients with hepatocellular carcinoma treated with sorafenib in the clinical practice. The CARDIO‐SOR study
17. Disulfiram hepatotoxicity: Report of three cases
18. Low applicability of the ��six-and-twelve score� in hepatocellular carcinoma treated with drug-eluting beads transarterial chemoembolization
19. Additional file 7 of The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolization
20. Additional file 3 of The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolization
21. Additional file 5 of The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolization
22. Additional file 4 of The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolization
23. Additional file 6 of The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolization
24. Additional file 2 of The development of early ascites is associated with shorter overall survival in patients with hepatocellular carcinoma treated with drug-eluting embolic chemoembolization
25. THU-290 - Efficacy and safety of vaccination againts SARS-CoV-2 in patients with vascular liver disease
26. WED-290 - Predictive models of treatment benefit in patients with autoimmune hepatitis and decompensated cirrhosis at diagnosis
27. WED-300 - Variation in the presentation pattern of primary biliary cholangitis (PBC) in Spain according to the diagnostic period: data from the Spanish registry of cholestatic and autoimmune liver diseases (COLHAI)
28. WED-270 - Risk of decompensated cirrhosis in patients with primary biliary cholangitis under first, second and third-line therapies
29. GS-003 - Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebo-controlled trial
30. Persistently low platelet count and splenomegaly after treatment with oxaliplatin as markers of development of portal sinusoidal vascular disease
31. Comparative effects of second-line therapy with obeticholic acid or fibrates in primary biliary cholangitis patients
32. Usefulness of the “AFP model” to predict recurrence tumor in patients transplanted with carcinoma hepatocellular within Milan criteria
33. Influence of DAA treatment in patients with HCV-cirrhosis and esophageal varices on liver transplant free survival and risk of developing hepatocellular carcinoma
34. Analysis of the influence of alcoholic abstinence on mortality in patients with alcoholic liver cirrhosis
35. Usefulness of HEVantigen determination in the diagnosis of acute hepatitis E
36. Applicability of the “six and twelve model” in patients with hepatocellular carcinoma treated with DEB-TACE
37. Frequency and characteristics of DAAs failure in hepatitis C therapy
38. Role of immigration in chronic HBV and HCV infection in our environment. Origin and characteristics of the patients
39. Changes in the characteristics of hospital admissions due to decompensated cirrhosis in the era of direct-acting antivirals against hepatitis C virus
40. Diabetes is not associated with an increased risk of hepatocellular carcinoma in patients with alcoholic or hepatitis C virus cirrhosis
41. SAT-129-Type 2 diabetes in patients with liver cirrhosis: prevalence, associated factors and influence on survival
42. FRI-039-Autoimmune hepatitis-related cirrhosis: The importance of treatment response and the utility of Baveno VI criteria
43. SAT-489-Efficacy and safety of thermal ablation in patients with hepatocellular carcinoma and high comorbidity
44. SAT-460-Influence of sustained virological response in diagnostic performance of alpha-fetoprotein for hepatocellular carcinoma in patients with HCV-cirrhosis
45. FRI-022-Characteristics of autoimmune hepatitis with acute presentation
46. Giant biloma as a result of a blunt abdominal trauma: a case report
47. Giant biloma as a result of a blunt abdominal trauma: A case report
48. FRI126 - Comparative effects of second-line therapy with obeticholic acid or fibrates in primary biliary cholangitis patients.
49. THU065 - Analysis of the influence of alcoholic abstinence on mortality in patients with alcoholic liver cirrhosis.
50. SAT393 - Usefulness of HEVantigen determination in the diagnosis of acute hepatitis E.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.